CAS alert: COVID-19 Yellow Card reporting site launched by MHRA

06 May 2020

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Central Alerting System (CAS) alert to highlight the launch of a dedicated Yellow Card reporting site for healthcare products that are used in Coronavirus (COVID-19) treatment to be easily reported

The site can be accessed at:

Healthcare professionals, patients and carers are asked to report all suspected side effects to medicines or medical device adverse incidents related to COVID-19 treatment. This also includes medicines that patients and healthcare professionals are using off-label to treat COVID-19. Reporting for clinical trials should be in line with the trial protocols.


Read the full details in the CAS alert: